Targeted endothelial nanomedicine for common acute pathological conditions.
about
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.Targeting therapeutics to endothelium: are we there yet?Design Principles of Peptide Based Self-Assembled Nanomaterials.
P2860
Targeted endothelial nanomedicine for common acute pathological conditions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted endothelial nanomedicine for common acute pathological conditions.
@en
type
label
Targeted endothelial nanomedicine for common acute pathological conditions.
@en
prefLabel
Targeted endothelial nanomedicine for common acute pathological conditions.
@en
P2093
P2860
P1476
Targeted endothelial nanomedicine for common acute pathological conditions.
@en
P2093
Jacob S Brenner
Vladimir R Muzykantov
Vladimir V Shuvaev
P2860
P304
P356
10.1016/J.JCONREL.2015.09.055
P407
P577
2015-10-01T00:00:00Z